Measuring g-protein-coupled receptor signaling via radio-labeled GTP binding

Chirag Vasavda, Nicholas W. Zaccor, Paul C. Scherer, Charlotte Sumner, Solomon H Snyder

Research output: Contribution to journalArticle

Abstract

G-Protein-Coupled Receptors (GPCRs) are a large family of transmembrane receptors that play critical roles in normal cellular physiology and constitute a major pharmacological target for multiple indications, including analgesia, blood pressure regulation, and the treatment of psychiatric disease. Upon ligand binding, GPCRs catalyze the activation of intracellular G-proteins by stimulating the incorporation of guanosine triphosphate (GTP). Activated G-proteins then stimulate signaling pathways that elicit cellular responses. GPCR signaling can be monitored by measuring the incorporation of a radiolabeled and non-hydrolyzable form of GTP, [35S]guanosine-5'-O-(3-thio)triphosphate ([35S]GTPγS), into G-proteins. Unlike other methods that assess more downstream signaling processes, [35S]GTPγS binding measures a proximal event in GPCR signaling and, importantly, can distinguish agonists, antagonists, and inverse agonists. The present protocol outlines a sensitive and specific method for studying GPCR signaling using crude membrane preparations of an archetypal GPCR, the μ-opioid receptor (MOR1). Although alternative approaches to fractionate cells and tissues exist, many are cost-prohibitive, tedious, and/or require non-standard laboratory equipment. The present method provides a simple procedure that enriches functional crude membranes. After isolating MOR1, various pharmacological properties of its agonist, [D-Ala, N-MePhe, Gly-ol]-enkephalin (DAMGO), and antagonist, naloxone, were determined.

Original languageEnglish (US)
Article numbere55561
JournalJournal of Visualized Experiments
Volume2017
Issue number124
DOIs
StatePublished - Jun 9 2017

Fingerprint

G-Protein-Coupled Receptors
Guanosine Triphosphate
Radio
Proteins
GTP-Binding Proteins
Pressure regulation
Pharmacology
Guanosine 5'-O-(3-Thiotriphosphate)
Membranes
Enkephalins
Blood pressure
Physiology
Opioid Receptors
Naloxone
Analgesia
Psychiatry
Chemical activation
Tissue
Blood Pressure
Ligands

Keywords

  • Agonist
  • Antagonist
  • Biochemistry
  • Cellular fractionation
  • GPCR
  • GTPγS binding
  • Issue 124
  • Membrane preparation
  • Pharmacology
  • μ-opioid receptor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Measuring g-protein-coupled receptor signaling via radio-labeled GTP binding. / Vasavda, Chirag; Zaccor, Nicholas W.; Scherer, Paul C.; Sumner, Charlotte; Snyder, Solomon H.

In: Journal of Visualized Experiments, Vol. 2017, No. 124, e55561, 09.06.2017.

Research output: Contribution to journalArticle

@article{0c792962b5aa4887a009b04204dffa5d,
title = "Measuring g-protein-coupled receptor signaling via radio-labeled GTP binding",
abstract = "G-Protein-Coupled Receptors (GPCRs) are a large family of transmembrane receptors that play critical roles in normal cellular physiology and constitute a major pharmacological target for multiple indications, including analgesia, blood pressure regulation, and the treatment of psychiatric disease. Upon ligand binding, GPCRs catalyze the activation of intracellular G-proteins by stimulating the incorporation of guanosine triphosphate (GTP). Activated G-proteins then stimulate signaling pathways that elicit cellular responses. GPCR signaling can be monitored by measuring the incorporation of a radiolabeled and non-hydrolyzable form of GTP, [35S]guanosine-5'-O-(3-thio)triphosphate ([35S]GTPγS), into G-proteins. Unlike other methods that assess more downstream signaling processes, [35S]GTPγS binding measures a proximal event in GPCR signaling and, importantly, can distinguish agonists, antagonists, and inverse agonists. The present protocol outlines a sensitive and specific method for studying GPCR signaling using crude membrane preparations of an archetypal GPCR, the μ-opioid receptor (MOR1). Although alternative approaches to fractionate cells and tissues exist, many are cost-prohibitive, tedious, and/or require non-standard laboratory equipment. The present method provides a simple procedure that enriches functional crude membranes. After isolating MOR1, various pharmacological properties of its agonist, [D-Ala, N-MePhe, Gly-ol]-enkephalin (DAMGO), and antagonist, naloxone, were determined.",
keywords = "Agonist, Antagonist, Biochemistry, Cellular fractionation, GPCR, GTPγS binding, Issue 124, Membrane preparation, Pharmacology, μ-opioid receptor",
author = "Chirag Vasavda and Zaccor, {Nicholas W.} and Scherer, {Paul C.} and Charlotte Sumner and Snyder, {Solomon H}",
year = "2017",
month = "6",
day = "9",
doi = "10.3791/55561",
language = "English (US)",
volume = "2017",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "124",

}

TY - JOUR

T1 - Measuring g-protein-coupled receptor signaling via radio-labeled GTP binding

AU - Vasavda, Chirag

AU - Zaccor, Nicholas W.

AU - Scherer, Paul C.

AU - Sumner, Charlotte

AU - Snyder, Solomon H

PY - 2017/6/9

Y1 - 2017/6/9

N2 - G-Protein-Coupled Receptors (GPCRs) are a large family of transmembrane receptors that play critical roles in normal cellular physiology and constitute a major pharmacological target for multiple indications, including analgesia, blood pressure regulation, and the treatment of psychiatric disease. Upon ligand binding, GPCRs catalyze the activation of intracellular G-proteins by stimulating the incorporation of guanosine triphosphate (GTP). Activated G-proteins then stimulate signaling pathways that elicit cellular responses. GPCR signaling can be monitored by measuring the incorporation of a radiolabeled and non-hydrolyzable form of GTP, [35S]guanosine-5'-O-(3-thio)triphosphate ([35S]GTPγS), into G-proteins. Unlike other methods that assess more downstream signaling processes, [35S]GTPγS binding measures a proximal event in GPCR signaling and, importantly, can distinguish agonists, antagonists, and inverse agonists. The present protocol outlines a sensitive and specific method for studying GPCR signaling using crude membrane preparations of an archetypal GPCR, the μ-opioid receptor (MOR1). Although alternative approaches to fractionate cells and tissues exist, many are cost-prohibitive, tedious, and/or require non-standard laboratory equipment. The present method provides a simple procedure that enriches functional crude membranes. After isolating MOR1, various pharmacological properties of its agonist, [D-Ala, N-MePhe, Gly-ol]-enkephalin (DAMGO), and antagonist, naloxone, were determined.

AB - G-Protein-Coupled Receptors (GPCRs) are a large family of transmembrane receptors that play critical roles in normal cellular physiology and constitute a major pharmacological target for multiple indications, including analgesia, blood pressure regulation, and the treatment of psychiatric disease. Upon ligand binding, GPCRs catalyze the activation of intracellular G-proteins by stimulating the incorporation of guanosine triphosphate (GTP). Activated G-proteins then stimulate signaling pathways that elicit cellular responses. GPCR signaling can be monitored by measuring the incorporation of a radiolabeled and non-hydrolyzable form of GTP, [35S]guanosine-5'-O-(3-thio)triphosphate ([35S]GTPγS), into G-proteins. Unlike other methods that assess more downstream signaling processes, [35S]GTPγS binding measures a proximal event in GPCR signaling and, importantly, can distinguish agonists, antagonists, and inverse agonists. The present protocol outlines a sensitive and specific method for studying GPCR signaling using crude membrane preparations of an archetypal GPCR, the μ-opioid receptor (MOR1). Although alternative approaches to fractionate cells and tissues exist, many are cost-prohibitive, tedious, and/or require non-standard laboratory equipment. The present method provides a simple procedure that enriches functional crude membranes. After isolating MOR1, various pharmacological properties of its agonist, [D-Ala, N-MePhe, Gly-ol]-enkephalin (DAMGO), and antagonist, naloxone, were determined.

KW - Agonist

KW - Antagonist

KW - Biochemistry

KW - Cellular fractionation

KW - GPCR

KW - GTPγS binding

KW - Issue 124

KW - Membrane preparation

KW - Pharmacology

KW - μ-opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=85021199457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021199457&partnerID=8YFLogxK

U2 - 10.3791/55561

DO - 10.3791/55561

M3 - Article

C2 - 28654029

AN - SCOPUS:85021199457

VL - 2017

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 124

M1 - e55561

ER -